Eyerci Nilnur, Balkan Eda, Akdeniz Necmettin, Keleş Sadullah
Department of Medical Biology, Medicine Faculty of Kafkas University, Kars, Turkey.
Department of Medical Biology, Medicine Faculty of Atatürk University, Erzurum, Turkey.
Arch Rheumatol. 2018 Jan 31;33(3):352-357. doi: 10.5606/ArchRheumatol.2018.6704. eCollection 2018 Sep.
This study aims to investigate whether or not MHC class I polypeptide-related sequence A (MICA) polymorphisms are associated with the susceptibility to Behçet's disease (BD) in a Turkish population.
The study included 38 Turkish BD patients (20 males, 18 females; mean age 34±10.9 years) and 51 ethnically matched healthy controls (30 males, 21 females; mean age 36±12.8 years). MICA and human leukocyte antigen B (HLA-B) alleles were determined in all subjects by using the Luminex technology. LABType sequence-specific oligonucleotide MICA test (One Lambda) and sequence-specific oligonucleotide B locus tests (Gene-Probe) were used for the typing studies.
A total of 16 MICA alleles were found in BD patients as well as in control subjects. The gene frequency of MICA006 was significantly higher in the BD patients compared to controls (14.5% vs. 0.9%; odds ratio [OR]: 17.092 95% confidence interval [CI] [2.155~135.554]; p<0.05). When haplotypes were evaluated, an association was found between the haplotypes HLA-B51-MICA006 (11.8% and 0.9%; OR: 13.567 95% CI [1.679~109.577]; p<0.001) and HLA-B51-MICA009 (27.6% and 13.7%; OR: 2.4 95% CI [1.127~5.109]; p<0.05). Frequencies of HLA-B49-MICA004 (0% and 6.8%) and HLA-B52- MICA*009 (0% and 10.7%) were significantly higher in controls compared to BD patients (p<0.05).
Our study shows that the MICA006 (MICA-A6) and the MICA009 alleles are associated with BD susceptibility in HLA-B51 positive Turkish population, particularly in HLA-B51 patients with MICA*006, which might be considered as a diagnostic biomarker for BD in the future.
本研究旨在调查MHC I类多肽相关序列A(MICA)基因多态性是否与土耳其人群中白塞病(BD)的易感性相关。
本研究纳入了38例土耳其BD患者(20例男性,18例女性;平均年龄34±10.9岁)和51例种族匹配的健康对照者(30例男性,21例女性;平均年龄36±12.8岁)。采用Luminex技术测定所有受试者的MICA和人类白细胞抗原B(HLA - B)等位基因。LABType序列特异性寡核苷酸MICA检测(One Lambda)和序列特异性寡核苷酸B位点检测(Gene - Probe)用于分型研究。
在BD患者和对照者中总共发现了16个MICA等位基因。与对照组相比,BD患者中MICA006的基因频率显著更高(14.5%对0.9%;优势比[OR]:17.092,95%置信区间[CI][2.155~135.554];p<0.05)。当评估单倍型时,发现单倍型HLA - B51 - MICA006(11.8%和0.9%;OR:13.567,95% CI[1.679~109.577];p<0.001)和HLA - B51 - MICA009(27.6%和13.7%;OR:2.4,95% CI[1.127~5.109];p<0.05)之间存在关联。与BD患者相比,对照组中HLA - B49 - MICA004(0%和6.8%)和HLA - B52 - MICA*009(0%和10.7%)的频率显著更高(p<0.05)。
我们的研究表明,在HLA - B51阳性的土耳其人群中,MICA006(MICA - A6)和MICA009等位基因与BD易感性相关,特别是在携带MICA006的HLA - B*51患者中,这可能在未来被视为BD的一种诊断生物标志物。